It is known as a targeted therapy since it particularly targets the CD38 that are overexpressed to the multiple myeloma cells. Daratumumab is from a class of medicines named CD38 monoclonal antibodies. You might have Repeated liver functionality checks although employing this medicine and for several months after you cease. https://tommyw581ksy3.blogofchange.com/profile